Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal



Page Path
HOME > Search
1 "RhoJ"
Article category
Publication year
Identification of Novel Drug Targets for the Treatment of Diabetic Retinopathy
Akiyoshi Uemura
Diabetes Metab J. 2013;37(4):217-224.   Published online August 14, 2013
  • 3,851 View
  • 28 Download
  • 1 Crossref
AbstractAbstract PDFPubReader   

Vision loss in diabetic retinopathy (DR) is attributable to retinal vascular disorders that result in macular edema and neoangiogenesis. In addition to laser photocoagulation therapy, intraocular injections of antivascular endothelial growth factor drugs have contributed to the treatment of these disease conditions. Nonetheless, the clinical feasibility of intraocular drug administration has raised an increasing demand to develop alternative drugs that can fundamentally ameliorate the retinal vascular dysfunctions in DR. For this purpose, experimental animal models that reproduce human DR would be of clinical benefit. Despite the unavailability of DR models in rats or mice, pharmacological and genetic manipulations without hyperglycemia have successfully recapitulated retinal edema and neoangiogenesis in postnatal mouse retinas, thereby enabling the understanding of the pathophysiology underlying DR. This article highlights the utility of experimental mouse models of retinal vascular abnormalities and discusses cellular and molecular mechanisms responsible for the onset and progression of DR. These approaches will lead to the identification of novel drug targets for the restoration of vascular integrity and regeneration of functional capillaries in DR.


Citations to this article as recorded by  
  • A Protective Role for RHOJ in NonSmall Cell Lung Cancer Based on Integrated Bioinformatics Analysis
    Tian Zeng, Can Chen, Pan Yang, Wenwei Zuo, Xiaoqing Liu, Yanling Zhang
    Journal of Computational Biology.2020; 27(7): 1092.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer